ScoreWhy is Genpharmasec Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 4.13% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.64
2
Risky - Negative Operating Profits
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -57.36%, its profits have risen by 105% ; the PEG ratio of the company is 1.4
3
Below par performance in long term as well as near term
- Along with generating -57.36% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Trading & Distributors)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Genpharmasec for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Genpharmasec
-56.75%
-1.32
43.44%
Sensex
4.69%
0.40
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
26.42%
EBIT Growth (5y)
4.13%
EBIT to Interest (avg)
-0.64
Debt to EBITDA (avg)
3.26
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.98
Tax Ratio
58.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.11%
ROE (avg)
1.05%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
144
Industry P/E
29
Price to Book Value
1.21
EV to EBIT
-85.15
EV to EBITDA
85.15
EV to Capital Employed
1.19
EV to Sales
1.27
PEG Ratio
1.37
Dividend Yield
NA
ROCE (Latest)
-1.38%
ROE (Latest)
0.84%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
OPERATING CF(Y)
Highest at Rs 2.99 Cr
NET SALES(Q)
Highest at Rs 32.64 cr
-8What is not working for the Company
PBT LESS OI(Q)
At Rs -1.26 cr has Fallen at -769.0% (vs previous 4Q average
PAT(Q)
At Rs -1.18 cr has Fallen at -294.2% (vs previous 4Q average
EPS(Q)
Lowest at Rs -0.02
Loading Valuation Snapshot...
Here's what is working for Genpharmasec
Net Sales - Quarterly
At Rs 32.64 cr has Grown at 221.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 10.14 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 2.99 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 32.64 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Genpharmasec
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.26 cr has Fallen at -769.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -0.15 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -1.18 cr has Fallen at -294.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.61 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -0.02
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
